Healius (HLS)
20mins delayed
Movement
1 Year Return
Healius Chart
| Share price | |
| Last | |
| Change | |
| Volume | |
| Turnover | |
| Market Cap | $1.84 billion |
| Today's Movement | |
| Prev. Close | |
| Open | |
| Day Range | - |
| VWAP | |
| Historical Stats | |
| 52w Range | - |
| 4w Avg Volume | |
| 4w Avg Turnover | |
| (delayed) | |
HLS Statistics
18 April
171 / 2,323
ASX Size Rank
1yr Return
vs Sector (1yr)
-31.25%
vs ASX 200 (1yr)
-26.27%
$1.84 billion
Market Cap
Share Issue
622.32 million
All Ords (%)
0.09%
Short Sold
2.5%
Current Fundamentals
18 April
296
PE Ratio
EPS ($)
0.01
Earnings Yield
0.34%
NTA ($)
-1.05
3.14%
Dividend Yield
DPS ($)
0.093
Gross Div. Yield
4.49%
Gross DPS ($)
0.1328
Company Overview
Healius Limited (HLS, formerly Primary Health Care Limited) is a healthcare company providing service to medical and health professionals through its network of medical centres and pathology centres across Australia. HLS is also a provider of healthcare technology solutions to medical practitioners, medical practices and hospitals.
Former Names
Primary Health Care Limited (PRY), 04/12/2018
Upcoming Calendar
| 19 Aug 2019 | Report (Prelim) |
| 27 Sep 2019 | Report (Annual) |
| 14 Feb 2020 | Report (Interim) |
Dividend History
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 15/03/2019 | $0.038 | 100% | Interim | 26/03/2019 |
| 27/08/2018 | $0.055 | 100% | Final | 17/09/2018 |
See Upcoming Dividends for all ASX companies.
Announcements
| Date | Heading | Pages | File Size | Time |
|---|---|---|---|---|
Broker Consensus
The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.
HLS is not covered by a major broker.
Directors & Management
| Name | Title | Since | Bio |
|---|---|---|---|
| Mr David M Richwhite | Non-Executive Director | Aug 2018 |
|
| Mr Robert Hubbard | Non-Executive Director, Non-Executive Chairman | Dec 2014 |
|
| Dr Malcolm Parmenter | Chief Executive Officer, Managing Director | Sep 2017 |
|
| Ms Arlene May Tansey | Non-Executive Director | Aug 2012 |
|
| Mr Gordon Richard Davis | Non-Executive Director | Aug 2015 |
|
| Dr Paul Francis Jones | Non-Executive Director | Nov 2010 |
|
| Dr Errol Katz | Non-Executive Director | Nov 2010 |
|
| Maxine Jaquet | Chief Executive Health & Co | N/A | |
| Dean Lewsam | Chief Executive Imaging | N/A | |
| Timothy Haggett | Chief Executive Medical Centres | N/A | |
| Wesley Lawrence | Chief Executive Pathology | N/A | |
| Malcolm Ashcroft | Chief Financial Officer | N/A | |
| Charles Tilley | Company Secretary | N/A |
Director Transactions
HLS directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
| Date | Director | Type | Amount | Price | Value | Notes |
|---|---|---|---|---|---|---|
| 21/12/18 | Errol Katz | Buy | +13,080 | $2.250 | $29,430 | On-market trade. |
| 27/11/18 | Arlene Tansey | Buy | +4,000 | $2.520 | $10,080 | On-market trade. |
| 12/10/18 | Malcolm Parmenter | Issued | 527,178 | $2.820 | $1,486,641 | Issue of securities. |
| 14/09/18 | Arlene Tansey | Issued | 1,920 | $2.500 | $4,800 | Rights issue. |
| 14/09/18 | Robert Hubbard | Issued | 5,951 | $2.500 | $14,877 | Rights issue. |
| 14/09/18 | Malcolm Parmenter | Issued | 9,597 | $2.500 | $23,992 | Rights issue. |
| 14/09/18 | Gordon Davis | Issued | 5,759 | $2.500 | $14,397 | Rights issue. |
| 14/09/18 | Paul Jones | Issued | 6,536 | $2.500 | $16,340 | Rights issue. |
| 14/09/18 | Errol Katz | Issued | 1,920 | $2.500 | $4,800 | Rights issue. |
| 31/08/18 | Robert Hubbard | Buy | +15,000 | $2.790 | $41,850 | On-market trade. |
| 31/08/18 | Gordon Davis | Buy | +20,000 | $2.717 | $54,334 | On-market trade. |
| 19/02/18 | Paul Jones | Buy | +2,400 | $3.800 | $9,120 | On-market trade. |
Shareholder Distribution
| Holding Size | 1 - 1,000 | 1,001 - 5,000 | 5,001 - 10,000 | 10,001 - 100,000 | 100,001 and over | Total Shareholders |
|---|---|---|---|---|---|---|
| No. of Shareholders | 3,876 | 6,670 | 2,159 | 1,290 | 77 | 14,072 |
Top 20 Shareholders
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 171,103,309 | 29.28% |
| J P Morgan Nominees Australia Limited | 114,493,564 | 19.59% |
| Jangho Health Care Australia Pty Limited | 83,139,070 | 14.23% |
| National Nominees Limited | 49,986,250 | 8.55% |
| Citicorp Nominees Pty Limited | 30,684,982 | 5.25% |
| BNP Paribas Noms Pty Ltd |
11,632,679 | 1.99% |
| Argo Investments Limited | 9,307,750 | 1.59% |
| CS Third Nominees Pty Limited |
6,828,794 | 1.17% |
| CS Fourth Nominees Pty Limited |
6,102,777 | 1.04% |
| BNP Paribas Nominees Pty Ltd |
4,328,246 | 0.74% |
| Citicorp Nominees Pty Limited |
2,757,440 | 0.47% |
| HSBC Custody Nominees (Australia) Limited GSCO ECA | 2,505,364 | 0.43% |
| HSBC Custody Nominees (Australia) Limited |
2,158,327 | 0.37% |
| Rinrim Pty Limited | 1,962,000 | 0.34% |
| Bainpro Nominees Pty Limited | 1,930,448 | 0.33% |
| Charado Pty Ltd | 1,235,488 | 0.21% |
| AMP Life Limited | 1,117,374 | 0.19% |
| Warbont Nominees Pty Ltd |
1,065,230 | 0.18% |
| National Nominees Limited |
973,000 | 0.17% |
| Nulis Nominees (Australia) Limited |
962,831 | 0.16% |
| All other shareholders | 13.72 % | |
The Top 20 Shareholders of HLS hold 86.28% of shares on issue.
HLS Share Price History
| Date | Close | Change | % Change | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
HLS Historical Data
Download up to 20 years of share price history.
| Year | Closing Price (30 June) | Last Trade |
|---|
Offical data as published by ASX. See more Data Downloads.
Company Details
Principal Activity: A medical centre operator; a provider of diagnostic imaging services; a provider of pathology; and a provider of health technology.
Incorporated: Incorporated on 17 May 1994 in Victoria, Australia.
Level 6, 203 Pacific Hwy
St Leonards NSW 2065
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.